Decrease in extracellular Zn²⁺ in the hippocampus by zinc chelators. by Atsushi Takeda (18203)

“…To evaluate the effects of CQ (the left image of A and B, vehicle; the right image of A and B, CQ) and TPEN (he left image of C and D, vehicle; the right image of C and D, TPEN), CQ-injected (A and B) and TPEN-injected (C and D) groups were separately measured under the exactly same condition. …”

Decrease in the phosphorylation level of STAT3 after treatment with LIF MO. by Kazuhiro Ogai (622067)

Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes by Yun Wu (150224)

Subjects:

Discovery of IHMT-MST1-58 as a Novel, Potent, and Selective MST1 Inhibitor for the Treatment of Type 1/2 Diabetes by Yun Wu (150224)

Subjects:

Overexpression of a dominant negative alpha2-annexin::GFP (D122A, D275A) decreases ventral flagellar waveform amplitude with only slight decreases in attachment. by Susan A. House (191265)

“…(<b>B</b>) Overexpression of the dominant negative alpha2-annexin (D122A, D275A), or alpha2-annexin dn, results in a ventral flagellar (vf) beat with significantly decreased amplitude (n = 25; see also <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1002167#ppat.1002167.s004" target="_blank">Video S3</a>). …”

STAT6-driven immunity decreases <i>N</i>. <i>brasiliensis</i> reproductive output and survival within host. by Annabel A. Ferguson (17616286)

SAA and saaHDL decrease adiponectin secretion by hMADS adipocytes. by Aurélie Faty (169741)

Visual deprivation rescues the decrease in proliferative cells by HDAC1 knockdown. by Yi Tao (178829)

Iminosugar-based GCS inhibitors decrease brain GFAP positive cells. by Karen M. Ashe (349018)

Iminosugar-based GCS inhibitors decrease brain α-synuclein aggregates. by Karen M. Ashe (349018)

Percent positivity of HPV16 variant by 5-year age intervals. by Ana Alfaro (280118)

“…<p>The figure shows the percentage of HPV16 infections as a whole and as segregated by lineages D (D2 and D3) and A (A1/2) based on 5-year age intervals for all CC patients (n = 462). …”

Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer by Ana Alfaro (280118)

“…Interestingly, when analyzing only the HPV16-positive CC, D2 increases (OR = 2.5, 95% CI = 1.2–5, p < 0.05) and D3 decreases (OR = 0.45, 95% CI 0.2–0.9, p < 0.05) the risk to develop CC before 50 years old in relation with A1/2 variant. …”

miR-275 and miR-305 maternal loss-of-function mutants exhibited impaired flight capability, decreased hatching rate and survival rate. by Junfei Xie (3148638)

Postnatal decrease in PV+ cortical interneurons in Fgfr1 mutant mice. by Karen Müller Smith (613941)

“…Scale bar is 50 µm in <b>A</b>,<b>B</b>. Stereological analysis show significant decreases in in both GFP and PV immunopositive cells in Fgfr1 mutant mice as compared to littermate controls (<b>C</b>). …”

Decrease in the number of prescriptions for antibiotics in percentage, by studies assessing this outcome parameter. by Christin Löffler (3539528)

Plasma membrane localized KCa3.1 is decreased by DN Rab1 and Rab8, but not by Rab2 or Rab6. by Claudia A. Bertuccio (309866)

“…<p>HEK293 cells were co-transfected with BLAP-KCa3.1 and either WT, DA or DN Rabs 1, 2, 6 or 8 and plasma membrane localized KCa3.1 evaluated by specific biotinylation, streptavidin labeling and IB (see Methods). As shown in <b>A</b> and <b>C</b>, DN Rab8 (T22N) and two different DN Rab1s (N124I, S25N) decreased expression of plasma membrane KCa3.1. …”

BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

“…(C) Compared to control, BT9 treatment significantly decreased the number of invading DAOY and D425 cells (****p < 0.0001, BT9 vs vehicle control, n = 6). 4x magnification.…”

Decrease in the interscale differentiation marker in senescence prone SAMP8 mice. by Gopakumar Changarathil (3479078)

Conditions that ablate cytonemes decrease signaling, reduce myoblast and tumor growth. by Sol Fereres (664350)

Combined EGCG/As decreases the viability of two types of EC, HUVEC and HBMEC. by Jee-Youn Kim (796526)